Skip to main content

Table 2 Demographic, Clinical and survival data

From: Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder

 

RTEL1 mutation

RTEL1 WT

p values

Gender (M/F) (% of male)

92/59 (61)

222/139 (61)

ns

Age (M ± S.D.)

59.11 ± 16.32

65.5 ± 14.22

< 0.0001

Days of Hospitalization (M ± S.D.)

22.15 ± 16.08

27.28 ± 34.48

0.048

Bilateral pneumoniae (yes/no) (%yes)

51 (34)

137 (38)

ns

Oxygen Administration (yes/no) (%yes)

104 (69)

332 (92)

0.0023

Type of oxygen Therapy

   

 Nasal cannula (%)

72 (48)

166(46)

0.0117

 CPAP/High Flows (%)

46 (31)

148 (41)

 

 Intubation (%)

33 (21)

46 (13)

 

Survival (Death) (%death)

12 (8%)

22 (6%)

ns

Number of comorbidities

  

ns

 No comorbidities

59

46

 

 1

18

28

 

 2

12

13

 

 3

10

9

 

 > 4

1

4

Â